Back to Market返回行情

CERO CERo Therapeutics Holdings, Inc.

OTCHealthcare

$0.0100+8.11%ClosedMarket Cap: $451,124

As of 2026-10-07 15:43

Why CERO matters now

CERo Therapeutics Holdings, Inc. (CERO) is a US stock in Healthcare. The latest InvestLog snapshot shows $0.01 with +8.11% on the session and $451.1K in market capitalization.

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

OTC

Beta

0.16

CERo Therapeutics Holdings, Inc. is a biotech firm dedicated to pioneering advanced engineered T-cell immunotherapies for the treatment of various cancers. Their leading therapeutic candidate, CER-1236, is an autologous T-cell therapy currently in development, aimed at addressing both blood cancers (hematologic malignancies) and solid tumors. This company was founded in 2021 and is headquartered in South San Francisco, California.